Skip to content
Stop using now Drug recall · FDA · Published September 4, 2014

Hospira Recalls Bupivacaine HCl Due to Particulate Matter

Hospira Inc. recalls specific lots of Bupivacaine HCl injection due to brown, rust-colored particles found in glass vials.

🇺🇸 FDA recall #D-1588-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling a specific lot of Bupivacaine HCl Injection, USP, 0.5% because a customer complaint confirmed the presence of brown, rust-colored particulate matter inside the glass vial. This recall affects 75,000 vials distributed nationwide. The product is intended for nerve block, caudal, and epidural anesthesia but is not for spinal anesthesia. Read more at govinfonow.com/recall/45770-hospira-inc-recalls-bupivacaine-hcl-inj-usp-0-5-5.

Source Summary by GovInfoNow · govinfonow.com/recall/45770-hospira-inc-recalls-bupivacaine-hcl-inj-usp-0-5-5 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1588-2014

Cite this page

“Hospira Recalls Bupivacaine HCl Due to Particulate Matter.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45770-hospira-inc-recalls-bupivacaine-hcl-inj-usp-0-5-5. Based on FDA recall #D-1588-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1588-2014%22&limit=1).

The FDA announced on Sept. 4, 2014, that Hospira Inc. voluntarily recalled Bupivacaine HCl Inj., USP, due to the presence of particulate matter. The agency issued recall number D-1588-2014 for the Class II drug.

How to tell if you have it

  • Brand: Hospira
  • Product: Bupivacaine HCl Injection
  • NDC: 0409-1162-02
  • Lot code: 37-268-DK
  • Expiration date: 1JAN2016
  • Quantity: 75,000 vials

The hazard

A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial. The hazard is classified as the presence of particulate matter.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls include a 2017-04-21 Infant Dextrose Injection recall for hair particulates and a 2016-11-01 Fentanyl Injection recall for broken ampule tips. Similar recent recalls of other products include an American Regent Papaverine HCl Injection recall (2026-07-24), a B. Braun Medical Lactated Ringer's Injection recall (2026-08-12), and a GE Healthcare Omnipaque Injection recall (2026-03-24).

How to tell if you have this one

Check for Bupivacaine HCl Inj., USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative-Free vials manufactured by Hospira, Inc. Look for NDC 0409-1162-02 and Lot number 37-268-DK with an expiration date of 1JAN2016.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Product

    Do not use any vials matching the recalled lot number due to the presence of particulate matter.

  2. Contact Healthcare Provider

    If you have received this product, contact your healthcare provider immediately for guidance on next steps.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: Sep 4, 201412. FDA classified it Class II: Sep 17, 201423. Published in FDA’s Enforcement Report: Sep 24, 201434. FDA terminated the recall: Jul 23, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1588-2014 (September 4, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1588-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA